Cilostazol
- TRADE NAME: Pletal (Otsuka)
- INDICATIONS: Peripheral vascular disease, intermittent claudication
- CLASS: Antiplatelet (antithrombotic), Phosphodiesterase inhibitor, Vasodilator, peripheral
- HALF-LIFE: 11–13 hours
Anagrelide, Anticoagulants, Antifungals, Antiplatelet agents, Clarithromycin, Collagenase, Conivaptan, CYP2C19 inhibitors, CYP3A4 inducers or inhibitors, Dasatinib, Deferasirox, Diltiazem, Drotrecogin Alfa, Erythromycin, Esomeprazole, Fondaparinux, Glucosamine, Grapefruit Juice, High-fat foods, Ibritumomab, Itraconazole, Ketoconazole, Macrolide antibiotics, NSAIDs, Omeprazole, PEG-Interferon, Pentosan, Pentoxifylline, Prostacyclin analogues, Salicylates, St John's Wort, Telithromycin, Thrombolytic agents, Tositumomab & Iodine131, Voriconazole
PREGNANCY CATEGORY: C
Contra-indicated in patients with congestive heart failure or active pathological bleeding.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 09/01/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric